Rockville, March 02, 2023 (GLOBE NEWSWIRE) -- Fact. MR’s latest survey on the intracranial aneurysm market provides a detailed analysis of growth drivers, market restraints, and emerging trends ...

Endovascular therapy is feasible and relatively safe for many asymptomatic unruptured intracranial aneurysms, according to a registry study published online July 30, 2013, ahead of print in Stroke.

Endovascular coiling to treat ruptured and unruptured intracranial aneurysms offers high long-term occlusion rates in elderly patients, according to a meta-analysis published in the July 2013 issue of ...

Use of GLP-1s is linked to lower risk for subarachnoid hemorrhage and mortality in patients with intracranial aneurysms and type 2 diabetes compared to use of other agents, a new study shows.

The global intracranial aneurysm treatment market is on the brink of significant expansion, with a projected Compound Annual Growth Rate (CAGR) of 8.8% from 2022 to 2032. Market analysts anticipate an ...

Researchers at the RIKEN Center for Brain Science (CBS) in Japan have discovered a set of related mutations that lead to intracranial aneurysms—weakened blood vessels in the brain that can burst at ...

Mortality rates after treatment of unruptured intracranial aneurysms have substantially decreased in the past decade, according to new findings presented today at the Society of NeuroInterventional ...

April 6, 2011 — NeuroVasx's cPAX Aneurysm Treatment System was approved by the US Food and Drug Administration (FDA) this week as a humanitarian use device for the treatment of cerebral aneurysms.

A brain (cerebral) aneurysm is a weak spot in an artery in the brain that swells and fills with blood. The bulging area within a cerebral aneurysm can put pressure on surrounding tissue or a nerve.